Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
RX
- Prescription Medicines
METRONIDAZOL ARENA 125 mg
Antimicrobial and antiparasitic drug, indicated in anaerobic and parasitic infections
Capsules
125 mg
METRONIDAZOL ARENA 250mg
Antimicrobial and antiparasitic drug, indicated in anaerobic and parasitic infections
Tablets
250mg
METRONIDAZOL ARENA 500 mg
Antimicrobial and antiparasitic drug, indicated in anaerobic and parasitic infections
Capsules
500 mg
MIRTAZAPIN ARENA 15 mg
Antidepressant drug with noradrenergic and serotonergic action, indicated in the treatment of depression
Film-coated tablets
15 mg
MIRTAZAPIN ARENA 30 mg
Antidepressant drug with noradrenergic and serotonergic action, indicated in the treatment of depression
Film-coated tablets
30 mg
MIRTAZAPIN ARENA 45 mg
Antidepressant drug with noradrenergic and serotonergic action, indicated in the treatment of depression
Film-coated tablets
45 mg
MONTELUKAST ARENA 10 mg
Leukotriene receptor antagonist, indicated in the treatment of asthma and allergic rhinitis
Film-coated tablets
10 mg
MONTELUKAST ARENA 4 mg
Leukotriene receptor antagonist, indicated in the treatment of asthma and allergic rhinitis
Chewable tablets
4 mg
MONTELUKAST ARENA 5 mg
Leukotriene receptor antagonist, indicated in the treatment of asthma and allergic rhinitis
Chewable tablets
5 mg